Transvaginal mesh lawsuit removed from state court, expected to join multidistrict litigation
A transvaginal mesh lawsuit against manufacturer Johnson & Johnson will remain in federal court, and claims against the surgeon who implanted the mesh will be thrown out, a U.S. District judge ruled after concluding the physician was added to the
Could erectile dysfunction drug Viagra help relieve pain from menstrual cramps?
The so-called “little blue pill” that treats erectile dysfunction in men, may provide relief for women who suffer from painful menstrual cramps, according to a new study published in the journal Human Reproduction.
Actos label updated to advise against use in pediatric patients with type 2 diabetes
The type 2 diabetes drug Actos is not recommended for children or adolescents because of potentially dangerous side effects including fluid retention and congestive heart failure, fractures and urinary bladder tumors, according to an update to the drug’s safety label.
PPI treatment Prevpac linked to serious hypersensitivity reactions
A new hypersensitivity reaction warning has been added to the safety label of the prescription proton pump inhibitor (PPI) Prevpac, a package of medications used to treat stomach ulcers, gastroesophageal reflux disease (GERD), damaged esophaguses, and conditions that cause the
Dr. Oz slams new guidelines that dramatically broaden indication for cholesterol-lowering statins
Popular television talk show host Dr. Oz is no fan of the controversial new guidelines that dramatically broaden the indication for cholesterol-lowering statin medications.
FDA panel questions whether bowel disease drug increases risk of deadly brain infection
A Food and Drug Administration (FDA) advisory panel is questioning the safety of Takeda Pharmaceutical’s inflammatory bowel disease drug candidate vedolizumab, claiming the drug could cause patients to develop a rare but deadly brain infection. The panel is set to
Johnson & Johnson company to pay $1.25 million to settle adulterating, misbranding claims
The Food and Drug Administration (FDA) has reached a $1.25 million settlement against Advanced Sterilization Products (ASP), a division of Ethicon Inc., a Johnson & Johnson company, and two of ASP’s executives over the manufacturing and distributing of adulterated and
Judge delays C.R. Bard transvaginal mesh trial amid settlement talks
A federal bellwether trial against transvaginal mesh maker C.R. Bard that was scheduled to start Dec. 3 has been pushed back to January 10, 2014. C.R. Bard is one of six transvaginal mesh manufacturers facing more than 30,000 personal injury
Rate of blood clots with Thoratec heart pump device has increased dramatically
A higher rate of blood clots has been seen in patients who received the Thoratec Corp’s HeartMate II heart pump than was noted during clinical trials or from prior experience, and when blood clots do form they occur closer to